Eli Lilly on Thursday expanded its direct-to-consumer online platform LillyDirect to include telehealth providers to diagnose ...

Alzheimer’s disease doesn’t have a cure, meaning no treatment can reverse the damage that’s already occurred in the brain.

A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...

Research shows experimental anti-amyloid drug reduced cognitive symptom risk by 50% in people with rare genetic mutations ...

For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...

Eli Lilly is expanding its menu of direct-to-consumer healthcare offerings. | Eli Lilly is expanding its menu of ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

An experimental treatment appears to delay Alzheimer's symptoms in some people genetically destined to get the disease in ...

Certain widely used drug combinations may either slow down or worsen the progression of Alzheimer's disease, but their ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

New research identifies 16 genes linked to Alzheimer's risk while experts emphasize powerful lifestyle changes that could ...

To determine the underlying causes of neuronal vulnerability at the earliest stages of Alzheimer's Disease (AD), a research ...